METASTATIC PROSTATE CANCER
Clinical trials for METASTATIC PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PROSTATE CANCER trials appear
Sign up with your email to follow new studies for METASTATIC PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for advanced prostate cancer: experimental drug GDC-1261 enters early trials
Disease control Not yet recruitingThis study tests a new drug called GDC-1261 in people with advanced or metastatic prostate cancer that has worsened despite prior treatment. The main goals are to check the drug's safety, find the best dose, and see if it can slow the cancer. About 260 participants will take part…
Matched conditions: METASTATIC PROSTATE CANCER
Phase: PHASE1, PHASE2 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated May 26, 2026 04:22 UTC
-
Could surgery after hormone therapy curb advanced prostate cancer?
Disease control Not yet recruitingThis study looks at men with advanced prostate cancer that has spread to other parts of the body. After 6 months of hormone therapy, those whose scans show no active cancer may be randomly assigned to either continue hormone therapy alone or also have their prostate removed. The …
Matched conditions: METASTATIC PROSTATE CANCER
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated May 26, 2026 03:54 UTC
-
Diabetes drug shows promise against advanced prostate cancer in new trial
Disease control Not yet recruitingThis phase 2 trial tests whether adding dapagliflozin, a common diabetes medication, to standard hormone therapy can help control metastatic prostate cancer better than hormone therapy alone. About 60 adults with advanced prostate cancer that has spread and is no longer respondin…
Matched conditions: METASTATIC PROSTATE CANCER
Phase: PHASE2 • Sponsor: Yung NA • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New hope for advanced prostate cancer: drug combo trial launches
Disease control Not yet recruitingThis study tests two experimental drugs (AZD9574 and AZD2265) in people with metastatic prostate cancer that has spread. The goal is to check safety and see if the combination can shrink tumors or lower PSA levels. About 152 participants will join this early-phase trial at multip…
Matched conditions: METASTATIC PROSTATE CANCER
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 19, 2026 11:59 UTC
-
New hope for tired prostate cancer patients: low dose naltrexone tested in clinical trial
Symptom relief Not yet recruitingThis study tests whether a small daily dose of naltrexone (3 mg) can reduce fatigue in men with prostate cancer who are receiving hormone therapy (ADT). The trial will enroll 60 participants and measure changes in tiredness, quality of life, and safety. It is a Phase 2 study, mea…
Matched conditions: METASTATIC PROSTATE CANCER
Phase: PHASE2 • Sponsor: University of Arkansas • Aim: Symptom relief
Last updated May 26, 2026 04:13 UTC
-
AI-Powered registry tracks Real-World use of prostate cancer drug
Knowledge-focused Not yet recruitingThis study will collect information from medical records of about 753 people with metastatic prostate cancer who have received a radioactive drug called lutetium-177. Researchers will use artificial intelligence to analyze treatment patterns, patient characteristics, and outcomes…
Matched conditions: METASTATIC PROSTATE CANCER
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated May 26, 2026 04:16 UTC
-
Can a prostate drug make hidden cancer light up on scans?
Knowledge-focused Not yet recruitingThis study looks at whether taking a short course of the drug bicalutamide can make PSMA PET/CT scans better at finding small amounts of prostate cancer that standard scans miss. It involves 20 adults with recurrent prostate cancer and very low PSA levels. Participants are random…
Matched conditions: METASTATIC PROSTATE CANCER
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated May 22, 2026 14:03 UTC
-
Brazilian study maps genetic secrets of advanced prostate cancer
Knowledge-focused Not yet recruitingThis study aims to understand genetic changes in metastatic prostate cancer and how they affect patient outcomes. It will involve 100 adults in Brazil who are receiving standard palliative therapy. Researchers will analyze tumor and blood samples to identify key mutations, but no…
Matched conditions: METASTATIC PROSTATE CANCER
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC